Literature DB >> 11112155

Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis.

M Dohi1, T Hasegawa, K Yamamoto, B C Marshall.   

Abstract

We investigated the in vivo effects of recombinant human hepatocyte growth factor (HGF) on epithelial cell proliferation in normal mouse lung and on the repair process that follows bleomycin-induced lung injury. Intratracheal administration of 100 micrograms of rhHGF to C57BL/6 mice led to proliferation of bronchial and alveolar epithelial cells as indicated by an increased number of cells staining for proliferating cell nuclear antigen (PCNA). The effect of HGF on the lung repair process was examined by administration of 100 micrograms of rhHGF on Day 3 and Day 6 after intratracheal injection of bleomycin to mice. We found that HGF significantly attenuated collagen accumulation induced by bleomycin as determined by quantitation of hydroxyproline content and by scoring of the extent of fibrosis. To explore the potential mechanisms involved in the beneficial effects of HGF, we performed in vitro studies with A549 pulmonary epithelial cells and found that HGF enhanced cell surface plasmin generation, expression of u-PA activity, and cell migration. In summary, HGF has potent in vivo and in vitro effects on epithelial cells, which suggests it may have a role in the therapy of pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112155     DOI: 10.1164/ajrccm.162.6.9908097

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  43 in total

Review 1.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.

Authors:  Kristy A Bauman; Scott H Wettlaufer; Katsuhide Okunishi; Kevin M Vannella; Joshua S Stoolman; Steven K Huang; Anthony J Courey; Eric S White; Cory M Hogaboam; Richard H Simon; Galen B Toews; Thomas H Sisson; Bethany B Moore; Marc Peters-Golden
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 3.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

4.  Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Authors:  Ana L Mora; Mauricio Rojas; Annie Pardo; Moises Selman
Journal:  Nat Rev Drug Discov       Date:  2017-10-30       Impact factor: 84.694

5.  Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon.

Authors:  Ying Xia; Yu-Feng Xia; Qi Lv; Meng-Fan Yue; Si-Miao Qiao; Yan Yang; Zhi-Feng Wei; Yue Dai
Journal:  Br J Pharmacol       Date:  2016-02-25       Impact factor: 8.739

6.  In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung.

Authors:  K Nakagome; M Dohi; K Okunishi; R Tanaka; J Miyazaki; K Yamamoto
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

7.  Mesenchymal stromal cells from neonatal tracheal aspirates demonstrate a pattern of lung-specific gene expression.

Authors:  Paul D Bozyk; Antonia P Popova; John Kelley Bentley; Adam M Goldsmith; Marisa J Linn; Daniel J Weiss; Marc B Hershenson
Journal:  Stem Cells Dev       Date:  2011-04-06       Impact factor: 3.272

8.  Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7.

Authors:  Manasi N Shukla; Jane L Rose; Rabindranath Ray; Kira L Lathrop; Anuradha Ray; Prabir Ray
Journal:  Am J Respir Cell Mol Biol       Date:  2008-11-06       Impact factor: 6.914

9.  Hepatocyte growth factor inhibits apoptosis by the profibrotic factor angiotensin II via extracellular signal-regulated kinase 1/2 in endothelial cells and tissue explants.

Authors:  Young H Lee; Ana P Marquez; Ognoon Mungunsukh; Regina M Day
Journal:  Mol Biol Cell       Date:  2010-10-06       Impact factor: 4.138

10.  Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease.

Authors:  Jaume Sauleda; Aina Noguera; David Blanquer; Jaume Pons; Meritxell López; Cristina Villena; Alvar G N Agustí
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.